My research interests
- Use of imaging methods (Optical Coherence Tomography, OCT and magnetic resonance imaging, MRI) to understand and quantify neurodegenerative processes in neuroinflammatory diseases
- Development of patient-friendly retinal markers of progression in multiple sclerosis (MS) and other neurological diseases
- Investigation of the visual pathway as a model of neurodegeneration
- Migraine and central pain (imaging and other biomarkers, treatment response)
- Multidisciplinary therapeutic approaches in MS (e.g., music therapy)
Selected Publications
Cerdá-Fuertes, Nuria, Stoessel, Marc, Mickeliunas, Gintaras, Pless, Silvan, Cagol, Alessandro, Barakovic, Muhamed, Maceski, Aleksandra Maleska, Álvarez González, Cesar, D’ Souza, Marcus, Schaedlin, Sabine, Benkert, Pascal, Calabrese, Pasquale, Gugleta, Konstantin, Derfuss, Tobias, Sprenger, Till, Granziera, Cristina, Naegelin, Yvonne, Kappos, Ludwig, Kappos, Ludwig, et al. (2023). Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis. Multiple Sclerosis Journal, 29(13), 1540–1550. https://doi.org/10.1177/13524585231198760
Cerdá-Fuertes, Nuria, Stoessel, Marc, Mickeliunas, Gintaras, Pless, Silvan, Cagol, Alessandro, Barakovic, Muhamed, Maceski, Aleksandra Maleska, Álvarez González, Cesar, D’ Souza, Marcus, Schaedlin, Sabine, Benkert, Pascal, Calabrese, Pasquale, Gugleta, Konstantin, Derfuss, Tobias, Sprenger, Till, Granziera, Cristina, Naegelin, Yvonne, Kappos, Ludwig, Kappos, Ludwig, et al. (2023). Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis. Multiple Sclerosis Journal, 29(13), 1540–1550. https://doi.org/10.1177/13524585231198760
Cagol A, Fuertes NC, Stoessel M, Barakovic M, Schaedelin S, D’Souza M, Würfel J, Brandt AU, Kappos L, Sprenger T, Naegelin Y, Kuhle J, Granziera C, & . (2023). Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis. Journal of Neurology, 270(4), 2139–2148. https://doi.org/10.1007/s00415-022-11535-8
Cagol A, Fuertes NC, Stoessel M, Barakovic M, Schaedelin S, D’Souza M, Würfel J, Brandt AU, Kappos L, Sprenger T, Naegelin Y, Kuhle J, Granziera C, & . (2023). Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis. Journal of Neurology, 270(4), 2139–2148. https://doi.org/10.1007/s00415-022-11535-8
, Oertel FC, Chien C, Kuchling J, Zimmermann HG, Siebert N, Motamedi S, Souza M, Asseyer S, Bellmann-Strobl J, Ruprecht K, Chakravarty MM, Scheel M, Magon S, Wuerfel J, Paul F, & Brandt AU. (2021). Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal study. NeuroImage: Clinical, 30, 102608. https://doi.org/10.1016/j.nicl.2021.102608
, Oertel FC, Chien C, Kuchling J, Zimmermann HG, Siebert N, Motamedi S, Souza M, Asseyer S, Bellmann-Strobl J, Ruprecht K, Chakravarty MM, Scheel M, Magon S, Wuerfel J, Paul F, & Brandt AU. (2021). Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal study. NeuroImage: Clinical, 30, 102608. https://doi.org/10.1016/j.nicl.2021.102608
, Gaetano L, Pfister A, Altermatt A, Tsagkas C, Morency F, Brandt AU, Hardmeier M, Chakravarty MM, Descoteaux M, Kappos L, Sprenger T, & Magon S. (2019). Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway. Neurology, 92(19), E2240–E2249. https://doi.org/10.1212/wnl.0000000000007450
, Gaetano L, Pfister A, Altermatt A, Tsagkas C, Morency F, Brandt AU, Hardmeier M, Chakravarty MM, Descoteaux M, Kappos L, Sprenger T, & Magon S. (2019). Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway. Neurology, 92(19), E2240–E2249. https://doi.org/10.1212/wnl.0000000000007450